Financial impact on social security of the incorporation of adalimumab for the treatment of hidradenitis suppurativa: An analysis of the 61-million-contributor Brazilian Social Security System (INSS).
Luiza Ferreira Vieira d'AlmeidaAna Claudia Borghi de OliveiraBeatriz Carvalho NeivaVanessa Queiroz BastosMarcos Paulo GodinhoDavid Rubem AzulayCiro Martins GomesPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)